RF RDN

SPYRAL HTN-OFF and -ON MED 24-Month Results: BP Reductions After RF RDN

04/02/2025

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Cath Lab Digest or HMP Global, their employees, and affiliates.

In a moderated abstract presentation at the CRT 2025 meeting held in Washington, D.C., Joachim Weil, MD, Director of the Heart and Vascular Center at Sana Kliniken Lübeck, Germany, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a period of two years.